Results of the Landmark RECORD Programme

Widening the Gap Between Risk and Benefit

The RECORD Programme

Xarelto Countdown

Potential Health Economics Benefits of 'Xarelto'

Desirable Characteristics of an Anticoagulant

Mode of Action of ‘Xarelto’

Challenging the Burden of Mortality in ACS

Highly Effective Protection with Xarelto^®

One-Tablet, Once-Daily Xarelto^® Adds Simplicity to Stroke Prevention

Xarelto® (rivaroxaban): The First Single-Drug Solution for VTE Treatment (Summary)

Xarelto® (rivaroxaban) is Highly Effective in Treating Acute DVT and Preventing Recurrent VTE

Xarelto® (rivaroxaban): A Single-Drug Solution for the Treatment of DVT, and Prevention of Recurrent DVT and PE

Reassuring Safety Profile of Xarelto

History of Warfarin